1.
Mennini FS, Marcellusi A, Viti R, Andreoni M. Willingness to pay for innovation: the case of the anti-HCV drugs from the Italian National Health Service perspective: Disponibilità a pagare e innovazione: il caso dei farmaci anti-HCV nel Sistema Sanitario Italiano. Grhta [Internet]. 2015 Oct. 7 [cited 2024 Nov. 21];2(2):69-77. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/329